CHAN MEDICAL SOLUTIONS LIMITED

Company Registration Number:
08409682 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

CHAN MEDICAL SOLUTIONS LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

CHAN MEDICAL SOLUTIONS LIMITED

Balance sheet

As at 31 March 2023


Notes

2023

2022


£

£
Current assets
Debtors: 3 12,826 1,852
Cash at bank and in hand: 119,076 105,195
Total current assets: 131,902 107,047
Creditors: amounts falling due within one year: 4 (12,546) (2,683)
Net current assets (liabilities): 119,356 104,364
Total assets less current liabilities: 119,356 104,364
Total net assets (liabilities): 119,356 104,364
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 119,256 104,264
Shareholders funds: 119,356 104,364

The notes form part of these financial statements

CHAN MEDICAL SOLUTIONS LIMITED

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 02 November 2023
and signed on behalf of the board by:

Name: Dr L Chan
Status: Director

The notes form part of these financial statements

CHAN MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover comprises the fair value of consultancy and training services received and receivable for the year.

CHAN MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 0 0

CHAN MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Debtors

Debtors for both the year ended 31 March 2023 and 31 march 2022 comprise only trade debtors.

CHAN MEDICAL SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Creditors: amounts falling due within one year note

Creditors at 31 March 2023 comprise trade creditors £4,671, taxation £3,517 and other creditors £4,358.Creditors at 31 March 2022 comprise trade creditors nil, taxation £1,453 and other creditors £1,230.